Nomura Holdings Inc Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Nomura Holdings Inc

  • $41.1 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$233.81 - $287.01 $1.71 Million - $2.1 Million
-7,300 Reduced 82.95%
1,500 $412,000
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $1.26 Million - $2.17 Million
8,800 New
8,800 $2.14 Million
Q3 2023

Nov 14, 2023
BUY
$170.77 - $211.65 $1.2 Million - $1.48 Million
7,000 New
7,000 $1.24 Million
Q2 2022

Aug 15, 2022
BUY
$120.42 - $169.29 $7.23 Million - $10.2 Million
60,000 New
60,000 $8.88 Million

Others Institutions Holding ALNY

# of Institutions
645
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.22M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email